Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Longo Medical AB
AB
Active
Org 5593905507
Bockholmsättra Gård
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 733K
+353% vs 2024
EBITDA margin
6.9%
+113% vs 2024
Equity ratio
86.2%
Financial strength
Net profit 2025
SEK 40K
+110% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 733K
+353%
EBITDA
SEK 51K
+113%
Net profit
SEK 40K
+110%
Total assets
SEK 76K
—
Equity
SEK 65K
+118%
Employees
3
—
Company information
Legal name
Longo Medical AB
Org number
5593905507
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
25 juli 2022
Share capital
SEK 25 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom medicin och bioteknik
Contact
Address
Bockholmsättra Gård
Email
hans.frykman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2023
0M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
1 630
162
733
Staff expenses
−1 243
−528
−674
EBITDA
364
−391
51
Depreciation & amort.
—
—
—
EBIT
364
−391
51
Net financials
1
8
—
Profit before tax
347
−383
51
Tax
−31
—
−10
Net profit
316
−383
40
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
439
0
76
Equity
341
−358
65
Long-term debt
—
—
—
Short-term debt
80
0
10
Total debt
80
—
10
Financial ratios
5-year trend
EBITDA margin
6.9%
This company
15.8%
Market median
-56% vs market
2023
2025
Equity ratio
86.2%
This company
38.2%
Market median
+126% vs market
2023
2025
Return on equity
61.6%
This company
18.4%
Market median
+235% vs market
2023
2025
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
2023
2025
Asset turnover
9.70×
This company
1.12×
Market median
+766% vs market
2023
2025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-25 – 2023-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
RR
Roopa Reddy
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MJ
Mats Jonas Gudmundsson
Deputy Board Member
2022
Former (1)
HB
Hans Birger Frykman
Board of Directors
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Longo Medical AB also hold positions in
0
other companies.
Person
Role here
Other companies
Roopa Reddy
Chief Executive Officer
0 companies
Mats Jonas Gudmundsson
Deputy Board Member
0 companies
Hans Birger Frykman
Board of Directors
0 companies